









市場行情
/
股票
/
nasdaq-icui
/

ICU Medical Inc

ICUI

142.670USD

-1.960-1.36%

收盤 12/31, 16:00（美東）報價延遲15分鐘

3.52B總市值

虧損本益比TTM



ICU Medical Inc

142.670

-1.960-1.36%

概覽公司財務分析

概覽

公司

財務

分析

關於 ICU Medical Inc 公司

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

ICU Medical Inc簡介



公司代碼ICUI

公司名稱ICU Medical Inc

上市日期Mar 31, 1992

CEOJain (Vivek)

員工數量15000

證券類型Ordinary Share

年結日Mar 31

公司地址951 Calle Amanecer

城市SAN CLEMENTE

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編92673-6212

電話19493662183

網址https://www.icumed.com/

公司代碼ICUI

上市日期Mar 31, 1992

CEOJain (Vivek)

ICU Medical Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

11.30K

-20.41%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

Ms. Laurie Hernandez

Independent Director

3.61K

+91.41%

Ms. Kolleen T. Kennedy

Independent Director

3.29K

+110.31%

Ms. Elisha W. Finney

Independent Director

3.25K

Mr. Donald M. Abbey

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Vivek Jain

Chairman of the Board, Chief Executive Officer

155.21K

-29.08%

Mr. Brian Michael Bonnell

Chief Financial Officer, Treasurer

30.35K

+21.62%

Mr. Daniel (Dan) Woolson

President

11.30K

-20.41%

Mr. David C. Greenberg, J.D.

Lead Independent Director

8.46K

+16.53%

Mr. Christian B. Voigtlander

Chief Operating Officer

6.09K

+154.83%

Mr. David F. Hoffmeister

Independent Director

4.75K

+56.92%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Infusion Consumables

273.13M

49.76%

Consumables

273.13M

49.76%

Infusion Systems

167.70M

30.55%

Vital Care

108.04M

19.68%

地區USD

名稱

營收

佔比

United States

335.43M

61.11%

EMEA

99.06M

18.05%

APAC

58.40M

10.64%

Others

55.97M

10.20%

業務

地區

業務USD

名稱

營收

佔比

Infusion Consumables

273.13M

49.76%

Consumables

273.13M

49.76%

Infusion Systems

167.70M

30.55%

Vital Care

108.04M

19.68%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.04%

The Vanguard Group, Inc.

10.61%

Janus Henderson Investors

10.02%

Wasatch Global Investors Inc

10.01%

Fuller & Thaler Asset Management Inc.

5.61%

其他

50.72%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.04%

The Vanguard Group, Inc.

10.61%

Janus Henderson Investors

10.02%

Wasatch Global Investors Inc

10.01%

Fuller & Thaler Asset Management Inc.

5.61%

其他

50.72%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

56.82%

Investment Advisor

46.66%

Hedge Fund

8.58%

Research Firm

2.66%

Corporation

1.90%

Pension Fund

1.43%

Sovereign Wealth Fund

1.17%

Individual Investor

0.96%

Bank and Trust

0.64%

機構持股



更新時間: 6 小時前

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

603

29.26M

118.52%

+2.55M

2025Q3

610

27.90M

113.00%

+1.26M

2025Q2

610

25.98M

105.53%

-2.00M

2025Q1

626

27.13M

110.25%

-2.28M

2024Q4

608

26.46M

107.92%

-3.56M

2024Q3

587

26.75M

109.35%

-2.77M

2024Q2

567

27.24M

111.60%

-1.50M

2024Q1

579

26.01M

106.82%

-1.69M

2023Q4

588

25.74M

106.69%

-1.14M

2023Q3

580

26.53M

109.94%

-1.49M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

3.22M

13.04%

-42.28K

-1.30%

Sep 30, 2025

The Vanguard Group, Inc.

2.62M

10.61%

-33.51K

-1.26%

Sep 30, 2025

Janus Henderson Investors

2.47M

10.02%

+3.39K

+0.14%

Sep 30, 2025

Wasatch Global Investors Inc

2.47M

10.01%

+2.47M

Jun 30, 2025

Fuller & Thaler Asset Management Inc.

1.39M

5.61%

-4.81K

-0.35%

Sep 30, 2025

Millennium Management LLC

1.09M

4.41%

+690.69K

+173.40%

Sep 30, 2025

State Street Investment Management (US)

917.13K

3.72%

-10.67K

-1.15%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

872.99K

3.54%

+126.07K

+16.88%

Sep 30, 2025

Schroder Investment Management North America Inc.

796.70K

3.23%

+160.38K

+25.20%

Sep 30, 2025

Columbia Threadneedle Investments (US)

763.73K

3.09%

+187.22K

+32.48%

Sep 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco S&P SmallCap Health Care ETF

1.82%

State Street SPDR S&P Health Care Equipment ETF

1.6%

JPMorgan Active Small Cap Value ETF

0.79%

Invesco S&P SmallCap 600 Pure Growth ETF

0.78%

JPMorgan Fundamental Data Science Small Core ETF

0.68%

Invesco NASDAQ Future Gen 200 ETF

0.51%

iShares S&P Small-Cap 600 Growth ETF

0.47%

State Street SPDR S&P 600 Small Cap Growth ETF

0.41%

OneAscent Enhanced Small and Mid Cap ETF

0.4%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.38%

Invesco S&P SmallCap Health Care ETF

佔比1.82%

State Street SPDR S&P Health Care Equipment ETF

佔比1.6%

JPMorgan Active Small Cap Value ETF

佔比0.79%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.78%

JPMorgan Fundamental Data Science Small Core ETF

佔比0.68%

Invesco NASDAQ Future Gen 200 ETF

佔比0.51%

iShares S&P Small-Cap 600 Growth ETF

佔比0.47%

State Street SPDR S&P 600 Small Cap Growth ETF

佔比0.41%

OneAscent Enhanced Small and Mid Cap ETF

佔比0.4%

Vanguard S&P Small-Cap 600 Growth Index Fund

佔比0.38%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

ICU Medical Inc的前五大股東是誰？



ICU Medical Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：3.22M
佔總股份比例：13.04%。
The Vanguard Group, Inc.
持有股份：2.62M
佔總股份比例：10.61%。
Janus Henderson Investors
持有股份：2.47M
佔總股份比例：10.02%。
Wasatch Global Investors Inc
持有股份：2.47M
佔總股份比例：10.01%。
Fuller & Thaler Asset Management Inc.
持有股份：1.39M
佔總股份比例：5.61%。